Tag: OPDP

CHC_FDA-Regulatory Images1

11/30/2017

OPDP’s Third Enforcement Letter of 2017 Cites Presentation of Risks, Efficacy Claims

CHC_FDA-Regulatory Images1

11/17/2017

DTC Docket Draws Health Professional, Consumer Comments

CHC_general1

09/08/2017

OPDP Issues Warning Letter for Omission of Risks, Material Facts

CHC_DTCadvertisement1

08/22/2017

FDA Opens Docket on Limiting Risk Communication in DTC Ads

CHC_DTCadvertisement2

06/20/2017

OPDP to Conduct DTC Survey about Internet Access, Opening Risk Statements